Korea Kolmar Co.
VC Fund
Seoul, South Korea
Korea Kolmar Co. is a VC fund in Seoul focused on Biotechnology and Medical. Korea Kolmar Co. engaged in the manufacture and sale of cosmetics. The Company operates in two divisions: cosmetics and pharmaceuticals. Its cosmetics division involves in the business of original development and design manufacturing (ODM) and original equipment manufacturing (OEM) of cosmetics including skin care, makeup, hair care, body care andothers. Its pharmaceutical division involves in the development and production of pharmaceutical products and quasi-drugs including general medicines, specialized medicines, bioequivalence medicines and others.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 31%
Last updated:
For AI agents: llms.txt
Industries Korea Kolmar Co. invests in
Stages Korea Kolmar Co. invests in
Countries Korea Kolmar Co. invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $1.5M–$2.2M
Investment Focus
Industry
- Biotechnology 4 (31%)
- Medical 3 (23%)
- Beauty 2 (15%)
- Pharmaceutical 2 (15%)
- B2B 1 (8%)
Stage
- Seed 4 (31%)
- Series B 2 (15%)
- Funding Round 2 (15%)
- Series A 1 (8%)
- Series C 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Choi Hak-bae
President
|
President | Total investments: 0 | Find email | |
|
Ho-Kyung Lee
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
The SMC Group
|
The SMC Group is a social marketing company. | $13M / Jun 18, 2026 | |
Woojung Bio
|
Woojung Bio is a bio infrastructure development company that constructs smart laboratories animal rooms for the purpose of research. | $23.6M / Post-IPO Debt / Mar 05, 2026 | |
Bistool
|
Bistool provides Facial silicone implant silicone prosthesis Soft Seal, including rhinoplasty prostheses, and used products in domestic cosmetic surgery clinics. | $2.2M / Seed / Jun 10, 2025 | |
MyIB
|
MyIB offers a matching gift program for businesses.MyIB commodities enterprises have a software platform called 'Give & Match' as well as a matching gift program. | Seed / May 30, 2024 | |
|
MyIB
|
MyIB offers a matching gift program for businesses.MyIB commodities enterprises have a software platform called 'Give & Match' as well as a matching gift program. | Seed / Apr 02, 2024 | |
ProEn Therapeutics
|
ProEn Therapeutics is a bio-drug development company that focuses on protein engineering. | Corporate Round / Mar 04, 2024 | |
Brexogen
|
Brexogen is a biotechnology cell therapy research and development company. | $9.1M / Series C / Sep 01, 2023 | |
|
Biome ATS
|
BioM ATS intends to provide the fundamental infrastructure required to progress the complex strain design platform and foster technical collaboration with microbiome firms through proof-of-concept (POC) of the complex strain design technology. It is a strategy to begin the platform business in earnest by the end of the year, with an emphasis onplatform advancement and collaboration with industry, academia, research institutes, and the military. | $1.5M / Seed / Jun 28, 2023 | |
Biomatz
|
Biomatz is a biotechnology company specializing in microbiome therapeutics. Their proprietary platform designs cooperative microbial consortia by isolating and analyzing complex gut microbiota interactions, facilitating the development of live biotherapeutic products. It aims to advance personalized medicine and gut health solutions withapplications spanning pharmaceuticals, nutraceuticals, and functional foods. | $1.5M / Seed / Jun 28, 2023 | |
Cell in Cells
|
Cell in Cells is a biotechnology and life sciences company. It is involved in cell therapy and regenerative medicine. The company developed Therapeutic Organoid Intelligence, a proprietary platform to harness cells' self-organizing potential to regenerate and restructure tissues without synthetic scaffolds. | $10.4M / Series B / Jul 26, 2021 | |
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Korea Kolmar Co. invest in?
Korea Kolmar Co. invests primarily in Biotechnology, Medical and Beauty startups, most often at Seed and Series B stage. Most of the 13 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Korea Kolmar Co.'s check size?
Korea Kolmar Co. typically joins rounds of $1.5M–$2.2M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Korea Kolmar Co. participates in.
How do I contact Korea Kolmar Co.?
Public channels for Korea Kolmar Co. include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Korea Kolmar Co.?
The team at Korea Kolmar Co. includes Choi Hak-bae (President) and Ho-Kyung Lee (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
